exploratory randomized clinical traial comparing naftopidil with tamsulosin in cases with benign prostatic hypertrophy assciated with overactive bladder

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: naftopidil 25mg to 75mg daily tamsulosin 0.2mg daily CONDITION: Benign prostatic hypertophy associated with overactive bladder PRIMARY OUTCOME: grade of desire for voiding measured by frequency volume chart SECONDARY OUTCOME: frequency of voiding, maximum voiding volume, average voiding volume INCLUSION CRITERIA: 1. previously untreated cases with benign prostatic hypertrophy 2. prostatic volume>=20ml 3. IPSS total score>=8 and QOL score>=2 4. Question 2 of IPSS>=2 5. Question 4 of IPSS>=2
Epistemonikos ID: 1708d037606dfd3f1b084cb14c1228bcf3b6fd36
First added on: Aug 22, 2024